Form 4 for LIF Life360, Inc.

Accepted 2024-06-20 00:00:00 ET · period of report 2024-06-17 · accession 0001581760-24-000066 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2024-06-20	2024-06-17	LIF	Hulls Chris	CEO, Dir	S - Sale	$27.00	-113.9K	1.83M	-6%	-$3.08M
I	2024-06-20	2024-06-17	LIF	Hulls Chris	CEO, Dir	S - Sale	$27.00	-8,355	1,846	-82%	-$225.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-06-17	S	D	113,890	$27.00	1,825,652	D Held by ICCA Labs, LLC	—	—	(F3) Includes common stock and the number of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. (F2) Includes 86,554 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. (F4) The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares sold and held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.
2	Common	Common stock	2024-06-17	S	D	8,355	$27.00	1,846	I	—	—	(F3) Includes common stock and the number of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.